Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yu Fan

Q1 2024 · 13F-HR

Yu Fanholdings as filed

Filed 2024-05-15 · accession 0000950123-24-005233

$72.5M
Reported value
5
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G72245106PRENETICS GLOBAL LTD$55.0M75.8%1,252,438CommonSOLE
00773J103CASTLE BIOSCIENCES INC$16.4M22.7%737,000CommonSOLE
835431107SONENDO INC$498,4410.69%22,503CommonSOLE
786700104SGMTSAGIMET BIOSCIENCES INC$309,9700.43%57,190CommonSOLE
747324101PYXSPYXIS ONCOLOGY INC$295,2310.41%69,303CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.